David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents | Charles Russell Speechlys

Skip to content

In the Press

You are here:

Home
News & Insights
In the Press
David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents

David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents

David Fyfield has been quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents.

Our thinking

Sara Wilson writes for Raconteur on menopause rights

Sara Wilson

In the Press
31 Jan 2023
Why employers must do more... Read More Why employers must do more...
Charles Russell Speechlys Intellectual Property team successfully oppose the registration of a certification mark for Manuka Honey

Mary Bagnall

News
26 Jan 2023
Charles Russell Speechlys Intellectual Property team successfully oppose the registration of a certification mark for Manuka Honey Read More Charles Russell Speechlys Intellectual Property team successfully oppose the registration of a certification mark for Manuka Honey
Is it really against the law to share your Netflix password?

Matthew Blakebrough

quick reads
25 Jan 2023
What did the Intellectual Property Office (IPO) Guidance say? The IPO issued some Guidance in December 2022 on The Effect of Piracy. The original d... Read More What did the Intellectual Property Office (IPO) Guidance say? The IPO issued some Guidance in December 2022 on The Effect of Piracy. The original d...
Katie Bewick writes for Independent Community Pharmacist on ways to remove a company director

Katie Bewick

In the Press
20 Jan 2023
Ways to remove a company director Read More Ways to remove a company director
Omnichannel innovation essential in the face of outlet decline

Caroline Swain

quick reads
19 Jan 2023
The UK's top 10 branded restaurants (by outlets) saw a combined decline of 0.8% in the total number of outlets in 2022 according to the Operator Da... Read More The UK's top 10 branded restaurants (by outlets) saw a combined decline of 0.8% in the total number of outlets in 2022 according to the Operator Da...
Fatima Mehdi writes for P3 Pharmacy on what operating as a private limited company means

Fatima Mehdi

In the Press
04 Jan 2023
Many pharmacy businesses in England and Wales are operated as private limited companies Read More Many pharmacy businesses in England and Wales are operated as private limited companies
EG quotes Louise Ward on the resilience of the life sciences sector in 2022

Louise Ward

In the Press
23 Dec 2022
“2022 has been a buoyant year for real estate transactions in the life sciences sector". Read More “2022 has been a buoyant year for real estate transactions in the life sciences sector".
Verdict quotes Nick White on his cryptocurrency predictions for 2023

Nick White

In the Press
23 Dec 2022
Following a string of scandals: where will the crypto industry go in 2023? Read More Following a string of scandals: where will the crypto industry go in 2023?
Sam Lawn writes for P3 Pharmacy on staff retention

Sam Lawn

In the Press
12 Dec 2022
"Staff are unlikely to commit themselves to a business if they are unable to progress there" Read More "Staff are unlikely to commit themselves to a business if they are unable to progress there"
The 12th Edition of the Nice Classification for Trade Marks includes blockchain goods and services

Chris Haywood

quick reads
23 Nov 2022
WIPO recently published its note on the upcoming 12th edition of the Nice Classification - confirming the standardised list of goods and services t... Read More WIPO recently published its note on the upcoming 12th edition of the Nice Classification - confirming the standardised list of goods and services t...
Instagram: NFT Factory and Marketplace

Anna Rogers

quick reads
11 Nov 2022
NFTs (or Non-Fungible Tokens) have been a hot topic for quite some time now, and rarely out of mainstream news. Parent company of Facebook, Meta an... Read More NFTs (or Non-Fungible Tokens) have been a hot topic for quite some time now, and rarely out of mainstream news. Parent company of Facebook, Meta an...
Henry Cuthbert writes for Law in Sport on Usain Bolt's move to trademark his legendary victory celebration

Henry Cuthbert

In the Press
31 Oct 2022
Trademarked For Success – What Can Athletes Learn From Usain Bolt’s Legendary Victory Celebration? Read More Trademarked For Success – What Can Athletes Learn From Usain Bolt’s Legendary Victory Celebration?
World Intellectual Property Review quotes Mary Bagnall on the Cadbury trademark win

Mary Bagnall

In the Press
12 Oct 2022
”We did the logically obvious thing, which was we filed a new mark, but deleted ‘or being the predominant colour‘.” Read More ”We did the logically obvious thing, which was we filed a new mark, but deleted ‘or being the predominant colour‘.”
A partnership for progress

Cara Imbrailo

Insights
03 Oct 2022
The rise of joint ventures in the UK’s life sciences sector. Read More The rise of joint ventures in the UK’s life sciences sector.
Eminem and Snoop Dogg Go Metaverse Live

Mark Hill

quick reads
20 Sep 2022
Eminem and Snoop Dogg performed their new single (which features two Bored Ape Yacht Club avatars, each owned by Slim Shady and the Doggfather) in ... Read More Eminem and Snoop Dogg performed their new single (which features two Bored Ape Yacht Club avatars, each owned by Slim Shady and the Doggfather) in ...
Charles Russell Speechlys advises Biolog-id on the execution of a Business Combination Agreement for proposed $312 million merger

Renaud Ferry

News
15 Sep 2022
Charles Russell Speechlys advises Biolog-id on the execution of a Business Combination Agreement for the proposed $312 million merger. Read More Charles Russell Speechlys advises Biolog-id on the execution of a Business Combination Agreement for the proposed $312 million merger.
The Grocer quotes Jamie Cartwright on the Celia Marsh inquest and allergen action

Jamie Cartwright

In the Press
07 Sep 2022
“Natasha’s Law responded to a perceived lack of accessible information on ingredients for consumers on the product itself..." Read More “Natasha’s Law responded to a perceived lack of accessible information on ingredients for consumers on the product itself..."
The Legal 500: Intellectual Property Country Comparative Guide

Mark Hill

Insights
07 Sep 2022
Charles Russell Speechlys is the exclusive contributor for the Legal 500 Intellectual Property Country Comparative Guide - UAE chapter. Read More Charles Russell Speechlys is the exclusive contributor for the Legal 500 Intellectual Property Country Comparative Guide - UAE chapter.
London’s role in the growing UK Life Sciences sector

Cara Imbrailo

Insights
06 Sep 2022
Mark Kildea, Howard de Walden’s Chief Executive and Cara Imrailo discuss Life Sciences opportunities in London Read More Mark Kildea, Howard de Walden’s Chief Executive and Cara Imrailo discuss Life Sciences opportunities in London
Lesley O'Leary writes for The Law Society Gazette on law firm strategy

Lesley O’Leary

In the Press
02 Sep 2022
‘You need to have a frank discussion about the things that matter to clients’ Read More ‘You need to have a frank discussion about the things that matter to clients’

Show all News & Insights

Share this Page

TOP